Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
![](https://www.pinterest.com/pin/create/button/?url=https://econotimes.com/Sanofi-Filing-of-the-2016-US-Form-20-F-and-French-Document-de-Rfrence-containing-the-Annual-Financial-Report-572603/&media=https://www.econotimes.com/assets/images/econotimes/metaDefault.png&description=Sanofi: Filing of the 2016 U.S. Form 20-F and French "Document de Référence" containing the Annual Financial Report - EconoTimes)
Filing of the 2016 U.S. Form 20-F and French "Document de Référence" containing the Annual Financial Report
Paris, France - March 3, 2017 - Sanofi announces today the filing of its Form 20-F with the U.S. Securities and Exchange Commission (SEC) and its "Document de Référence" containing its Annual Financial Report with the French market regulator Autorité des marchés financiers (AMF).
These documents are available on the "Investors" page of the company's corporate website (www.sanofi.com), under the heading "Regulated Information in France". In addition, the Form 20-F is available on the website of the SEC (www.sec.gov) and the "Document de Référence" is available on the website of the AMF (www.amf-france.org). A hard copy of these documents, each of which contains our complete audited financial statements, may be received free of charge, upon request.
About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Contacts:
| Media Relations Laurence Bollack Tel: + (33) 1 53 77 46 46 [email protected] | Investor Relations George Grofik Tel.: + (33) 1 53 77 45 45 [email protected] |
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/7e5eba72-9d79-4a4c-81e7-6ead57645fd3
